Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cells, covering 2014-12-31 to 2014-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis [NA]